ArticleCellular & molecular immunology2024

Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2.

Ronja Wieboldt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.